Tapani Viitala

机构：Research Council of Finland, Åbo Akademi University, University of Helsinki, Pharmaceutical Biotechnology (Czechia) · ORCID：0000-0001-9074-9450

发表论文 157 篇 · 总被引 5762 次 · h-index 42

代表论文

• Co‐delivery CPT and PTX prodrug with a photo/thermo‐responsive nanoplatform for triple‐negative breast cancer therapy (2022 · Smart Medicine · 被引 72)
• Monitoring silica core@shell nanoparticle‐bacterial film interactions using the multi‐parametric surface plasmon resonance technique (2023 · Smart Medicine · 被引 36)
• Vitamin C encapsulated biomimetic nanogels with macrophage membrane decoration for chronic wound healing (2024 · Chemical Engineering Journal · 被引 15)
• Rheological insights into 3D printing of drug products: Drug nanocrystal-poloxamer gels for semisolid extrusion (2024 · International Journal of Pharmaceutics · 被引 13)
• Exploiting the Warburg Effect: Co‐Delivery of Metformin and FOXK2 siRNA for Ovarian Cancer Therapy (2024 · Small Science · 被引 12)
• Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting (2023 · Frontiers in Immunology · 被引 12)